Jefferies assumed coverage of UCB (UCBJF) with an Underperform rating and EUR 212 price target Flagging recent slowing of U.S. volume trends, the firm sees 10%-15% downside to street Bimzelx estimates from 2026 and onward, the analyst tells investors.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UCBJF:
- UCB announces new three-year data from Phase 3 trials on BIMZELX
- UCB price target raised to EUR 290 from EUR 220 at Berenberg
- UCB price target raised to EUR 285 from EUR 250 at Deutsche Bank
- UCB price target raised to EUR 240 from EUR 220 at Morgan Stanley
- UCB added to European Conviction List at Goldman Sachs